Henry C Hrdlicka1, Sun-Kyeong Lee2, Anne M Delany1. 1. Center for Molecular Oncology, UConn Health, Farmington, CT 03030. 2. Center on Aging, UConn Health, Farmington, CT 03030.
Abstract
PURPOSE OF REVIEW: Our goal is to comprehensively review the most recent reports of microRNA (miRNA) regulation of osteoclastogenesis. We highlight validated miRNA-target interactions and their place in the signaling networks controlling osteoclast differentiation and function. RECENT FINDINGS: Using unbiased approaches to identify miRNAs of interest and reporter-3'UTR assays to validate interactions, recent studies have elucidated the impact of specific miRNA-mRNA interactions during in vitro osteoclastogenesis. There has been a focus on signaling mediators downstream of the RANK and CSF1R signaling, and genes essential for differentiation and function. For example, several miRNAs directly and indirectly target the master osteoclast transcription factor, Nfatc1 (e.g. miR-124 and miR-214) and Rho-GTPases, Cdc42 and Rac1 (e.g. miR-29 family). SUMMARY: Validating miRNA expression patterns, targets, and impact in osteoclasts and other skeletal cells is critical for understanding basic bone biology and for fulfilling the therapeutic potential of miRNA-based strategies in the treatment bone diseases.
PURPOSE OF REVIEW: Our goal is to comprehensively review the most recent reports of microRNA (miRNA) regulation of osteoclastogenesis. We highlight validated miRNA-target interactions and their place in the signaling networks controlling osteoclast differentiation and function. RECENT FINDINGS: Using unbiased approaches to identify miRNAs of interest and reporter-3'UTR assays to validate interactions, recent studies have elucidated the impact of specific miRNA-mRNA interactions during in vitro osteoclastogenesis. There has been a focus on signaling mediators downstream of the RANK and CSF1R signaling, and genes essential for differentiation and function. For example, several miRNAs directly and indirectly target the master osteoclast transcription factor, Nfatc1 (e.g. miR-124 and miR-214) and Rho-GTPases, Cdc42 and Rac1 (e.g. miR-29 family). SUMMARY: Validating miRNA expression patterns, targets, and impact in osteoclasts and other skeletal cells is critical for understanding basic bone biology and for fulfilling the therapeutic potential of miRNA-based strategies in the treatment bone diseases.
Authors: Song Yi Han; Na Kyung Lee; Kyung Hee Kim; In Whan Jang; Mijung Yim; Jae Hong Kim; Won Jae Lee; Soo Young Lee Journal: Blood Date: 2005-04-28 Impact factor: 22.113
Authors: H Kaneko; M Mehrotra; C Alander; U Lerner; C Pilbeam; L Raisz Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2007-10-24 Impact factor: 4.006
Authors: D Chatterjee; M Chakraborty; M Leit; L Neff; S Jamsa-Kellokumpu; R Fuchs; M Bartkiewicz; N Hernando; R Baron Journal: J Exp Biol Date: 1992-11 Impact factor: 3.312